Baidu
map
HPB 润色咨询

HPB

出版年份：暂无数据 年文章数：2537 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2023-02-12 ms6000000047448553 来自贵州省

    under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2023-02-12 ms6000000047448553 来自贵州省

    under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2023-02-01 ms6000000047448553 来自贵州省

    请问审稿人一般多久会接受审稿，投中率高吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2022-08-09 504528319

    投稿接近4个月了，还是under review

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2022-03-14 ms2000000659173864

    manuscript submitted 这个状态一周了。。。

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2022-04-18 YJJJJJ

    纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2022-05-14 钮祜禄

    请问这个杂志接受生信文章么

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2019-03-05 zhuqianzj

    文章上线后，wos收录很慢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2018-08-08 1de4cb95m75(暂无匿称)

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：肝胆外科领域口碑非常不错

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2114211, encodeId=36302114211d9, content=under review快半个月了 还是没有人接受审稿，投过的大佬可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:12:31 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2114210, encodeId=2cc82114210df, content=under review 快半个月了还是没有审稿人接受审稿...有经验的可以给个建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Sun Feb 12 11:11:12 CST 2023, time=2023-02-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2112601, encodeId=d833211260130, content=请问审稿人一般多久会接受审稿，投中率高吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34868363894, createdName=ms6000000047448553, createdTime=Wed Feb 01 17:10:09 CST 2023, time=2023-02-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1237583, encodeId=9b7a123e5836e, content=投稿接近4个月了，还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ffe2800746, createdName=504528319, createdTime=Tue Aug 09 15:00:30 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202466, encodeId=f0ab1202466af, content=manuscript submitted 这个状态一周了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf9d5507028, createdName=ms2000000659173864, createdTime=Mon Mar 14 13:56:08 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212229, encodeId=a7f0121222999, content=纯临床文章，审稿比较慢，意见很专业，3个月大修，2个月后接收，总共历时五个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Mon Apr 18 17:06:42 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219664, encodeId=4b951219664ae, content=请问这个杂志接受生信文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Sat May 14 21:59:48 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567666, encodeId=cc5a56e666fb, content=文章上线后，wos收录很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Tue Mar 05 00:00:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559955, encodeId=42b3559955a9, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：肝胆外科领域口碑非常不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/30/d455f5300307d053ccc6dcea37edc53f.jpg, createdBy=5efa1687467, createdName=1de4cb95m75(暂无匿称), createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554601, encodeId=13a655460123, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4371634937, createdName=zhuqianzj, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=)]
    2018-04-06 zhuqianzj

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：IHPBA官方期刊.肝胆胰外科领域极受认可!

    0

共21条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map